Filing Details
- Accession Number:
- 0001127602-24-028213
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-27 18:14:41
- Reporting Period:
- 2024-11-26
- Accepted Time:
- 2024-11-27 18:14:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc. | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1771814 | Jeffrey Bluestone | 333 Lakeside Drive Foster City CA 94404 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-26 | 5,879 | $61.17 | 11,587 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-11-26 | 4,121 | $61.35 | 15,708 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-26 | 6,788 | $91.39 | 8,920 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2024-11-26 | 5,879 | $0.00 | 5,879 | $61.17 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2024-11-26 | 4,121 | $0.00 | 4,121 | $61.35 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2030-12-08 | No | 4 | M | Direct | |
| 11,730 | 2032-05-05 | No | 4 | M | Direct |
Footnotes
- Sale prices reported for the transactions reported here range from $91.3901 to $91.3910. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- 25% of the shares subject to the option vest on each three-month anniversary measured from December 8, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable on December 8, 2021.
- 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022.
Billionaire Hedge Funds
